Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Doi

Showing results (71-80 of 247) with videos related to

Pageof 25
Sort By:
Cancer Medicine|September 9, 2021
Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 studyToshihiko Doi, Noboru Yamamoto, Yoichi Naito, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2014
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumorsToshihiko Doi, Yusuke Onozawa, Nozomu Fuse, et al.
British Journal of Cancer|November 26, 2019
Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Shigehisa Kitano, et al.
BMC Cancer|November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trialsYoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Japanese Journal of Clinical Oncology|July 28, 2007
Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancerNozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Two cases of KRAS wild-type unresectable or recurrent colorectal cancer effectively treated by cetuximab after progression of prior chemotherapy]Yusuke Yoda, Takayuki Yoshino, Shigenori Kadowaki, et al.
International Journal of Clinical Oncology|November 2, 2011
Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC?Yuki Nakajima, Sadamoto Zenda, Keiko Minashi, et al.
Japanese Journal of Clinical Oncology|July 5, 2012
Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignanciesSusumu Okano, Makoto Tahara, Sadamoto Zenda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric CancerYoon-Koo Kang, Yung-Jue Bang, Shunsuke Kondo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 23, 2012
Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patientsNozomu Fuse, Emiko Nagahisa-Oku, Toshihiko Doi, et al.
Pageof 25

Showing results (71-80 of 247) with videos related to

Sort By:
Pageof 25
Cancer Medicine|September 9, 2021
Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 studyToshihiko Doi, Noboru Yamamoto, Yoichi Naito, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2014
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumorsToshihiko Doi, Yusuke Onozawa, Nozomu Fuse, et al.
British Journal of Cancer|November 26, 2019
Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Shigehisa Kitano, et al.
BMC Cancer|November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trialsYoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Japanese Journal of Clinical Oncology|July 28, 2007
Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancerNozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Two cases of KRAS wild-type unresectable or recurrent colorectal cancer effectively treated by cetuximab after progression of prior chemotherapy]Yusuke Yoda, Takayuki Yoshino, Shigenori Kadowaki, et al.
International Journal of Clinical Oncology|November 2, 2011
Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC?Yuki Nakajima, Sadamoto Zenda, Keiko Minashi, et al.
Japanese Journal of Clinical Oncology|July 5, 2012
Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignanciesSusumu Okano, Makoto Tahara, Sadamoto Zenda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric CancerYoon-Koo Kang, Yung-Jue Bang, Shunsuke Kondo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 23, 2012
Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patientsNozomu Fuse, Emiko Nagahisa-Oku, Toshihiko Doi, et al.
Pageof 25